✦ LIBER ✦

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

✍ Scribed by Zheng Zhang; Hu Lin; Ming Shi; Ruonan Xu; Junliang Fu; Jiyun Lv; Liming Chen; Sa Lv; Yuanyuan Li; Shuangjie Yu; Hua Geng; Lei Jin; George K K Lau; Fu-Sheng Wang

Book ID: 111656473
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 788 KB
Volume: 27
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2011.07024.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Umbilical cord-derived mesenchymal stem

Umbilical cord-derived mesenchymal stem cell infusion improves liver function in liver cirrhosis and is associated with viral load reduction

✍ Chin, S.; Cheng, Z.; Then, K.; Cheong, S. 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 349 KB

1052 AUTOLOGOUS BONE MARROW MESENCHYMAL

1052 AUTOLOGOUS BONE MARROW MESENCHYMAL STEM CELL TRANSPLANTATION IN FIVE DECOMPENSATED LIVER CIRRHOSIS PATIENTS

✍ Park, C.-H.; Bae, S.H.; Kim, H.Y.; Song, M.J.; Jo, S.H.; Han, J.Y.; Yang, J.M.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

80 SAFETY AND TOLERABILITY OF HUMAN MESE

80 SAFETY AND TOLERABILITY OF HUMAN MESENCHYMAL STEM CELLS FOR PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A PRELIMINARY STUDY

✍ Fu, Q.; Jiang, S.; Wang, X.; Luo, Z.; Ni, L.; Ye, S.; Zhou, F.; Shi, L.; Chen, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

106: Phase 1 Trial of Autologous Bone Ma

106: Phase 1 Trial of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients With Decompensated Liver Cirrhosis

✍ K. Alimoghaddam; M. Mohamadnejad; M. Mohyedin Bonab; M. Bagheri; M. Bashtar; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Transplantation of human CD34+ stem cell

Transplantation of human CD34+ stem cells from umbilical cord blood to rats with thioacetamide-induced liver cirrhosis

✍ María José Sáez-Lara; Cecilia Frecha; Francisco Martín; Francisco Abadía; Miguel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

Rifaximin reduces endotoxemia and improv

Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis

✍ Georgios N. Kalambokis; Epameinondas V. Tsianos 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

We read with interest the article by Khalili et al. 1 addressing the management of small liver nodules detected in patients with cirrhosis under surveillance with abdominal ultrasound (US) that gave indeterminate results by contrast imaging. To optimize American Association for the Study of the Live